Post-approval studies (Phase 4)Study completedNCT06326034
What this trial is testing
Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients
Who this might be right for
Diabetic Nephropathy Type 2
Mohammed Mahmood Mohammed 40